As of 2025-10-26, the Relative Valuation of Biosynex SA (ALBIO.PA) is (36.98) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.65 EUR, the upside of Biosynex SA based on Relative Valuation is -5789.9%.
The range of the Relative Valuation is (32.88) - (39.45) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 21.3x | 17.8x |
| Forward P/E multiples | 11.4x - 17.0x | 14.2x |
| Fair Price | (32.88) - (39.45) | (36.98) |
| Upside | -5157.7% - -6169.2% | -5789.9% |
| Date | P/E |
| 2025-10-23 | -0.29 |
| 2025-10-22 | -0.29 |
| 2025-10-21 | -0.29 |
| 2025-10-20 | -0.29 |
| 2025-10-17 | -0.29 |
| 2025-10-16 | -0.30 |
| 2025-10-15 | -0.30 |
| 2025-10-14 | -0.29 |
| 2025-10-13 | -0.29 |
| 2025-10-10 | -0.29 |
| 2025-10-09 | -0.29 |
| 2025-10-08 | -0.30 |
| 2025-10-07 | -0.30 |
| 2025-10-06 | -0.28 |
| 2025-10-03 | -0.29 |
| 2025-10-02 | -0.30 |
| 2025-10-01 | -0.30 |
| 2025-09-30 | -0.30 |
| 2025-09-29 | -0.29 |
| 2025-09-26 | -0.27 |
| 2025-09-25 | -0.52 |
| 2025-09-24 | -0.52 |
| 2025-09-23 | -0.52 |
| 2025-09-22 | -0.51 |
| 2025-09-19 | -0.51 |
| 2025-09-18 | -0.52 |
| 2025-09-17 | -0.52 |
| 2025-09-16 | -0.52 |
| 2025-09-15 | -0.53 |
| 2025-09-12 | -0.52 |
| 2025-09-11 | -0.53 |
| 2025-09-10 | -0.51 |
| 2025-09-09 | -0.51 |
| 2025-09-08 | -0.51 |
| 2025-09-05 | -0.51 |
| 2025-09-04 | -0.51 |
| 2025-09-03 | -0.51 |
| 2025-09-02 | -0.51 |
| 2025-09-01 | -0.51 |
| 2025-08-29 | -0.51 |
| 2025-08-28 | -0.51 |
| 2025-08-27 | -0.51 |
| 2025-08-26 | -0.51 |
| 2025-08-25 | -0.51 |
| 2025-08-22 | -0.52 |
| 2025-08-21 | -0.51 |
| 2025-08-20 | -0.51 |
| 2025-08-19 | -0.51 |
| 2025-08-18 | -0.51 |
| 2025-08-15 | -0.52 |